If you are currently managing weight loss or type 2 diabetes, there is major news on the horizon. Orforglipron (now officially branded as Foundayo™) is the latest breakthrough in metabolic health. As a once-daily pill developed by Eli Lilly, it offers a powerful, needle-free alternative to injectable treatments like Wegovy or Mounjaro.
While 60% of Irish adults currently live with overweight or obesity, the primary medical solutions have been weekly injections. While effective, many patients find needles or strict refrigeration requirements a barrier to success. Foundayo aims to bridge that gap, earning nicknames like the “Daily GLP“ and the “Holy Grail Pill” in online health communities.
- Why Foundayo Is a Game Changer
Foundayo isn’t just “another weight loss pills.” It represents a major shift in drug development because it is a non-peptide small molecule.
Unlike current oral options (such as Rybelsus) that require you to fast for 30 minutes before taking them, Foundayo can be taken anytime, with or without food or water. This flexibility is why some early adopters are calling it the “Maintenance Pill”—an easy way to sustain weight loss without the “morning ritual” restrictions typical of other GLP-1 medications.
- Recent Clinical Breakthroughs
As of early 2026, clinical trial results have placed Foundayo in a league of its own for an oral medication:
- Superior Weight Loss: In the Phase 3 ATTAIN-1 trial, participants lost an average of 12.4% of their body weight over 72 weeks.
- Beating Oral Semaglutide: In the ACHIEVE-3 head-to-head trial published in The Lancet (February 2026), Foundayo delivered nearly double the weight loss of oral semaglutide (9.2% vs. 5.3%) and significantly better A1C reduction.
- Portable and Practical: Because it is a pill, it requires no refrigeration, making it a favorite for travelers and those with active lifestyles.
- Is Foundayo Available in Ireland?
Foundayo achieved a massive milestone on April 1, 2026, when it received FDA approval in the United States.
Currently, it is not yet licensed for use in Ireland. It is undergoing a rigorous review by the European Medicines Agency (EMA) and the Health Products Regulatory Authority (HPRA). While Eli Lilly is moving quickly with global submissions, we anticipate a potential launch in the Irish market by 2027.
Until then, Irish patients can rely on currently approved treatments. Online doctor services like Eirdoc Online Doctor provide expert guidance and prescriptions for existing weight loss injections following a comprehensive online assessment.
- Traditional Weight Loss Options in Ireland
While we wait for the “Oral Mounjaro“ (as some call it) to reach our shores, two main paths remain the standard of care:
- GLP-1 Injections: Weekly treatments like semaglutide (Wegovy) and tirzepatide (Mounjaro) are highly effective, with some patients losing between 11% and 21% of their body weight.
- Lifestyle Intervention: Medical weight management is most effective when paired with sustainable dietary changes and exercise, often under the supervision of a GP or specialist.
- The Road Ahead
Foundayo represents more than just a new pill; it represents accessibility. By removing the need for needles and cold-chain storage, it could significantly lower the cost of treatment and help solve the supply shortages that have affected injectable drugs for years.
The Bottom Line: Foundayo is the most exciting development in obesity care this decade, but it isn’t yet an option in Ireland. If you are ready to start your journey today, consult with a healthcare professional to explore the highly effective treatments already available.
-
What is Foundayo used for?
Foundayo (the brand name for orforglipron) is a once-daily oral pill used for chronic weight management and type 2 diabetes. It mimics the GLP-1 hormone to reduce appetite and lower blood sugar.
-
Has Foundayo been approved?
Yes. As of April 1, 2026, the FDA has approved Foundayo in the United States for weight management. Approval from the EMA (Europe) and HPRA (Ireland) is expected to follow, likely by 2027.
-
How can I get a weight loss prescription in Ireland now?
You can consult with your GP or use an online service like Eirdoc. After a medical evaluation, a doctor can prescribe currently authorized treatments such as Wegovy or Mounjaro if you meet the clinical criteria.
-
Why do people call it the "Holy Grail" or "Daily GLP"?
Because it is the first oral GLP-1 that doesn't require fasting or specific water intake. You can take it whenever it's convenient for you, which is a massive leap forward from older oral treatments.